Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Scora is a French specialty chemical company that is a global leader in the production of high-purity calcium and magnesium carbonates and compounds for the pharmaceutical and food industries. Founded in 1954 and acquired by ICL Group in 2014, the company operates a state-of-the-art, GMP-certified manufacturing facility in Caffiers, France. Its flagship products, including Scoralite and Scoramag, are widely utilized as active pharmaceutical ingredients (APIs) and excipients in antacids, mineral supplements, and bone health treatments. Scora's expertise lies in controlled precipitation and purification processes that ensure high bioavailability and strict compliance with international pharmacopoeia standards.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Scora.